Citation: Ar. Johnson et al., Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenol, BIOCHEM, 40(25), 2001, pp. 7736-7745
Authors:
O'Brien, PM
Ortwine, DF
Pavlovsky, AG
Picard, JA
Sliskovic, DR
Roth, BD
Dyer, RD
Johnson, LL
Man, C
Hallak, H
Citation: Pm. O'Brien et al., Structure-activity relationships and pharmacokinetic analysis for a seriesof potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors, J MED CHEM, 43(2), 2000, pp. 156-166
Authors:
Song, YT
Connor, DT
Doubleday, R
Sorenson, RJ
Sercel, AD
Unangst, PC
Roth, BD
Gilbertsen, RB
Chan, K
Schrier, DJ
Guglietta, A
Bornemeier, DA
Dyer, RD
Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series, J MED CHEM, 42(7), 1999, pp. 1151-1160
Authors:
Song, YT
Connor, DT
Sercel, AD
Sorenson, RJ
Doubleday, R
Unangst, PC
Roth, BD
Beylin, VG
Gilbertsen, RB
Chan, K
Schrier, DJ
Guglietta, A
Bornemeier, DA
Dyer, RD
Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazoleseries, J MED CHEM, 42(7), 1999, pp. 1161-1169
Citation: Yh. Wang et al., Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain, J BIOL CHEM, 274(46), 1999, pp. 33043-33049